Dose-Dependent Neuroprotective Effect of Standardized Bee Venom Phospholipase A2 Against MPTP-Induced Parkinson’s Disease in Mice
Parkinson’s disease (PD) is a chronic progressive neurodegenerative movement disorder characterized by the selective loss of dopaminergic neurons within the substantia nigra (SN). While the precise etiology of dopaminergic neuronal demise is elusive, multiple lines of evidence indicate that neuroinf...
Main Authors: | Kyung Hwa Kim, Seung Young Lee, Jaekwon Shin, Jae-Taeg Hwang, Hat Nim Jeon, Hyunsu Bae |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2019.00080/full |
Similar Items
-
Bee Venom Phospholipase A2: Yesterday’s Enemy Becomes Today’s Friend
by: Gihyun Lee, et al.
Published: (2016-02-01) -
Comparison of Administration Routes on the Protective Effects of Bee Venom Phospholipase A2 in a Mouse Model of Parkinson’s Disease
by: Hyunjung Baek, et al.
Published: (2018-06-01) -
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A2 in Mice
by: Dasom Shin, et al.
Published: (2016-04-01) -
Comparison of the Protective Effects of Bee Venom Extracts with Varying PLA<sub>2</sub> Compositions in a Mouse Model of Parkinson’s Disease
by: Kyung Hwa Kim, et al.
Published: (2019-06-01) -
Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer’s Disease via Inhibition of Nuclear Factor-Kappa B
by: Hyeon Joo Ham, et al.
Published: (2019-11-01)